There are several immunosuppressive pathways in the activation of T cells and the interaction of activated T cells with tumor cells, and existing immune checkpoint blockades target two specific pathways, CTLA-4/B7-1/2 and PD-1/PD-L1 (6). The gene discussed is PDCD1; the disease is neoplasm.